Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles

Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles

This study is focused on the selective delivery and release of the plant-based anticancer compound eugenol (EUG) in colorectal cancer cells (CRC). EUG is an apoptotic and anti-growth compound in diverse malignant tumors, including CRC. However, EUG’s rapid metabolization, excretion, and side effects...

Full description

Bibliographic Details
Main Authors: Nisitha Wijewantha, Sanam Sane, Morgan Eikanger, Ryan M. Antony, Rashaun A. Potts, Lydia Lang, Khosrow Rezvani, Grigoriy Sereda
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
drug-delivery system
nanoparticles
eugenol
colon cancer cells
apoptosis
Online Access:https://www.mdpi.com/2072-6694/15/4/1145

Similar Items

Similar Items